Public Health Agency of Canada
www.publichealth.gc.ca
Common menu bar links
Institutional links
Diseases & Conditions
Health & Safety
Research & Statistics
Agency Information
Search Box
A Report on Governments' Responses to the HIV/AIDS Epidemic in Canada
A National Portrait
Appendix D
Key Informants and Interview Guide
| Key Informants | Organization |
|---|---|
| British Columbia | |
| Warren O'Briain | Government |
| Dr. Perry Kendall | Government |
| Erik Ages | Community Organization |
| Mikki Hanson | Community Organization |
| Dr. Elizabeth Whynot | Provincial Heath Services Authority |
| Alberta | |
| Dr. Ameeta Singh | Government |
| Linda Findlay | Government |
| Dr. S. Houston | Government |
| Sherry McKibbon | Community Organization |
| Denise Lambert | Community Organization |
| Angela Kaida | Government |
| Saskatchewan | |
| John Mitchell | Government |
| Dr. Ross Findlater | Government |
| Christine Smith | Community Organization |
| Margaret Akan | Community Organization |
| Manitoba | |
| Trina Larsen | Government |
| Dr. Carole Beaudoin | Government |
| Michelyn Wood | Government |
| Daryn Bond | Community Organization |
| John Stinson | Community Organization |
| Ontario | |
| Frank McGee | Government |
| Dr. Robert Remis | University |
| Dr. Kirsten Rottensten | Government |
| Nancy Peroff | Government |
| Rick Kennedy | Community Organization |
| Quebec | |
| Lise Guérard | Government |
| Dr. Bruno Turmel | Government |
| Luc Gagnon | Community Organization |
| Mme Lyse Pinault | Community Organization |
| New Brunswick | |
| Maureen McIntosh | Government |
| Haley Flaro | Community Organization |
| Dr. Maureen Baikie | Government |
| Julie Dingwall | Community Organization |
| Nova Scotia | |
| Mahnaz FarhangMehr | Government |
| Larry Baxter | NS Advisory Commission |
| Robert Allen | Community Organization |
| Prince Edward Island | |
| Robin MacArthur | Health Canada |
| Barb Gibson | Community Organization |
| Newfoundland and Labrador | |
| Morgan Pond | Government |
| Cathy O'Keefe | Government |
| Michelle Boutcher | Community Organization |
| Nunavut | |
| Carolina Palacios | Government |
| Northwest Territories | |
| Dr. Kami Kandola | Government |
| Wanda White | Government |
| Jill Christensen | Community Organization |
| Yukon | |
| Dr. Bryce Larke | Government |
| Colleen Hemsley | Government |
| Janet LeCamp | Community Organization |
| Canada | |
| Dr. Christopher Archibald | Health Canada, PPHB |
| Jennifer Geduld | Health Canada, PPHB |
| Dr. Marcus Lem | Health Canada, FNIHB |
KEY INFORMANT INTERVIEW GUIDE
Note: Under "key informants" in the following Table:
- FPT - jurisdiction's representative on the FPT Advisory Committee.
- CMHO - jurisdiction's Chief Medical Health Officer
- OG - other government or Health Authority staff as identified by the FPT representative
- CR - representative(s) of community-based HIV/AIDS service or other organizations
| Policy and Program Issues | Key Informants | |
|---|---|---|
| A. | Administration and Delivery |
|
| 1. | Does your jurisdiction have a particular HIV/AIDS strategy or a series of activities and undertakings? Advantages/disadvantages? | FPT |
| CMHO | ||
| CR | ||
| 2. | Is there a lead government office directly responsible for HIV/AIDS-related matters? Responsibilities; number of staff? If "no," how are HIV/AIDS-related activities managed? | FPT |
| 3. | Is there an interdepartmental committee addressing HIV/AIDS-related issues? Who is involved; role? Accomplishments? | FPT |
| CMHO | ||
| OG | ||
| 4. | Are there regional or local health authorities in this jurisdiction and if so, what is their role in planning or administering the jurisdiction's response to HIV/AIDS? Links with the provincial/territorial authority? Are there regional HIV/AIDS service plans? How are access and service made consistent across regions? | FPT |
| OG | ||
| CR | ||
| B. | Coordination and Cooperation |
|
| 5. | Is there a committee or other structure for on-going liaison among government, community agencies and/or Health Authorities? Who is involved; roles, responsibilities and activities? Accomplishments and effectiveness? | FPT |
| OG | ||
| CR | ||
| 6. | Nature and extent of inter-governmental cooperation, e.g., with Health Canada or Correctional Service Canada? Other? Strengths & shortcomings? Means of improving? | FPT |
| 7. | Relationship, if any, with other health strategies? Funding, data or policy linkages? Strengths and shortcomings? | FPT |
| CMHO | ||
| OG | ||
| 8. | Advantages/disadvantages, challenges/opportunities associated with working cooperatively across jurisdictions, departments and health concerns? | FPT |
| CMHO | ||
| CR | ||
| C. | Funding |
|
| 9. | Does this jurisdiction specifically identify the funding committed to HIV/AIDS? How much and what is included in this calculation? | FPT |
| OG | ||
| 10. | (Where appropriate) What system is in place for allocating and spending HIV/AIDS-related funding via health authorities or community agencies? | FPT |
| OG | ||
| D. | Prevention, Treatment and Care |
|
| 11. | Are there specific efforts to educate/inform teachers, health care professionals or other groups about HIV/AIDS? Are protocols in place for health care professionals and/or others? | FPT |
| 12. | Are there specific efforts directed toward employers or the workplace? | FPT |
| 13. | Is there a special program for providing anti-retroviral drugs? Is the cost covered by government? | FPT |
| CMHO | ||
| 14. | Prenatal testing? Percentage take-up? Percentage of HIV-infected pregnant women receiving antiretrovirals? | FPT |
| CMHO | ||
| 15. | Special programs to meet the particular needs of those living with HIV/AIDS (housing, transportation, respite, hospice, etc.)? | FPT |
| OG | ||
| CR | ||
| E. | Testing |
|
| 16. | Jurisdiction's policies/protocols on HIV testing? Nominal, non-nominal, anonymous? Number or percent tested by year among pregnant women, inmates in correctional centres, and/or others? | FPT |
| H. | Knowledge, Research and Evaluation |
|
| 17. | Who is responsible for collecting, analyzing and disseminating epidemiological data? To what extent and how is information shared with Health Canada, other jurisdictions, municipalities, health authorities and NGOs/ASOs? Strengths/shortcomings of the national epi reporting system? | FPT |
| CR | ||
| 18. | To what extent do the jurisdictions fund research and evaluation, including community-based program evaluations? | FPT |
| CR | ||
| 19. | How is new knowledge concerning treatment or best practice disseminated? Efforts to apply new knowledge? Strengths and shortcomings of these efforts? | FPT |
| CR | ||
| I. | Conclusions and Recommendations |
|
| 20. | Anticipated trends, 2004 - 2010? | all |
| 21. | Issues of current concern? Emerging issues? | all |
| 22. | Means for strengthening the jurisdiction's response to HIV/AIDS? | all |
